PRL and breast cancer: Additionally, we analyzed the association of antipsychotics that increased the PRL level with breast cancer and obtained the following conclusions: no significant difference in breast cancer risk between typical and atypical antipsychotics was noted, and PRL-increasing and PRL-sparing antipsychotics pose a similar risk of breast cancer.